-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
OnKure Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2024.
- OnKure Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$15.4M, a 8.85% decline year-over-year.
- OnKure Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$60.3M, a 148% decline year-over-year.
- OnKure Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$52.7M, a 49.2% decline from 2023.
- OnKure Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$35.3M, a 32% increase from 2022.
- OnKure Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$52M, a 30.6% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)